Related Experiment Videos
Optimized microturbidimetric assay for fibrinogen
M Macart1, A Koffi, G Henocque
1Laboratoire du Centre Hospitalier de Laon, France.
Clinical Chemistry
|February 1, 1989
Summary
This study presents a new assay for measuring plasma fibrinogen levels using a precipitation method. The assay is accurate, precise, and minimally affected by common interfering substances, offering reliable results for clinical diagnostics.
Area of Science:
- Clinical Chemistry
- Biochemistry
- Hematology
Background:
- Accurate quantification of plasma fibrinogen is crucial for diagnosing and managing various hemostatic disorders.
- Existing methods for fibrinogen measurement can be susceptible to interference from various substances.
- Development of a robust and reliable fibrinogen assay is needed.
Purpose of the Study:
- To develop and validate a novel turbidimetric assay for plasma fibrinogen quantification.
- To assess the interference of common substances and monoclonal proteins on the assay's performance.
- To evaluate the assay's precision and correlation with established methods.
Main Methods:
- Plasma fibrinogen was precipitated using a reagent containing ammonium sulfate, EDTA, and guanidine hydrochloride.
- A two-step reagent addition and fixed reaction times were employed to minimize interference.
- The assay was calibrated with purified fibrinogen and validated against immunoturbidimetric, chronometric, and clotting assays.
Main Results:
- The assay demonstrated linear response from 0-10 g/L with within-run precision (CV) <2% from 1-10 g/L.
- Interference from bilirubin, hemoglobin, and chylomicrons was eliminated.
- Major interference from monoclonal proteins in adult samples was found to be very low (P = 0.0002).
- Extremely high correlations were observed with immunoturbidimetric (r=0.99), chronometric (r=0.99), and clotting (r=0.97) methods.
Conclusions:
- The developed turbidimetric assay provides a reliable, precise, and accurate method for plasma fibrinogen measurement.
- The assay is robust against common interfering substances and monoclonal proteins.
- This method offers a valuable alternative for routine clinical laboratory use in assessing fibrinogen levels.